Page last updated: 2024-08-22

buthionine sulfoximine and cytarabine

buthionine sulfoximine has been researched along with cytarabine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukushima, T; Takemura, H; Ueda, T; Urasaki, Y; Yoshida, A	1
Barge, RM; Honders, MW; Spoelder, HE; Veuger, MJ; Willemze, R	1

Other Studies

2 other study(ies) available for buthionine sulfoximine and cytarabine

Article	Year
Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells. Cancer research, 2001, Jan-01, Volume: 61, Issue:1 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; bcl-X Protein; Buthionine Sulfoximine; Cytarabine; Cytidine Deaminase; Daunorubicin; Deoxycytidine Kinase; DNA Fragmentation; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Glutathione; HL-60 Cells; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Multidrug Resistance-Associated Proteins; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Topoisomerase I Inhibitors	2001
Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in AraC and daunorubicin double resistant leukemic cell lines. Leukemia research, 2003, Volume: 27, Issue:5 Topics: 2-Chloroadenosine; Alternative Splicing; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azacitidine; Biological Transport; Buthionine Sulfoximine; Calcium Channel Blockers; Cytarabine; Daunorubicin; Decitabine; Deoxyadenosines; Deoxycytidine Kinase; DNA Mutational Analysis; DNA, Neoplasm; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione; Humans; Idarubicin; Leukemia; Methotrexate; Neoplasm Proteins; Rats; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Verapamil	2003

Article

Year

Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells.

Cancer research, 2001, Jan-01, Volume: 61, Issue:1

Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; bcl-X Protein; Buthionine Sulfoximine; Cytarabine; Cytidine Deaminase; Daunorubicin; Deoxycytidine Kinase; DNA Fragmentation; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Glutathione; HL-60 Cells; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Multidrug Resistance-Associated Proteins; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Topoisomerase I Inhibitors

2001

Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in AraC and daunorubicin double resistant leukemic cell lines.

Leukemia research, 2003, Volume: 27, Issue:5

Topics: 2-Chloroadenosine; Alternative Splicing; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azacitidine; Biological Transport; Buthionine Sulfoximine; Calcium Channel Blockers; Cytarabine; Daunorubicin; Decitabine; Deoxyadenosines; Deoxycytidine Kinase; DNA Mutational Analysis; DNA, Neoplasm; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione; Humans; Idarubicin; Leukemia; Methotrexate; Neoplasm Proteins; Rats; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Verapamil

2003